You are here

ArriVent Biopharma

Biopharma IPOs From the First Half of 2024

BioSpace

Thu, 05/30/24 - 11:17 am

Kyverna Therapeutics

ArriVent Biopharma

Alto Neuroscience

Contineum Therapeutics

Rapport Therapeutics

Telix Pharmaceuticals

ArriVent takes in $175M from second biotech IPO of the year

Fierce Biotech

Fri, 01/26/24 - 11:17 am

ArriVent Biopharma

non-small cell lung cancer

2024 Brings Surprising Early Surge of Biotech IPOs

BioSpace

Fri, 01/19/24 - 09:43 am

Alto Neuroscience

ArriVent Biopharma

Kyverna Therapeutics

Cancer biotech ArriVent Biopharma files for a $100 million IPO

Renaissance Capital

Mon, 01/8/24 - 11:38 am

ArriVent Biopharma

A lean first quarter for venture-backed developers

EP Vantage

Wed, 04/5/23 - 10:02 am

venture capital

ArriVent Biopharma

Flare Therapeutics GSK

With one of biotech's largest private rounds in a year, ArriVent enters PhIII

Endpoints

Mon, 03/27/23 - 11:25 am

ArriVent Biopharma